DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Cardiac Disease

Aortic Stenosis

HIGH SEVERITY

Narrowing of the aortic valve opening, restricting blood flow from the heart to the aorta. Most commonly caused by age-related calcification, congenital bicuspid valve, or rheumatic fever. Progressive disease; severe cases require valve replacement.

Global Affected

12.0M

Countries

89

Symptoms

Chest pain (angina)
Shortness of breath
Fatigue
Heart palpitations
Syncope (fainting)
Heart murmur
Reduced exercise tolerance
Swollen ankles/feet

Treatment Options

Surgical aortic valve replacement (SAVR)
Transcatheter aortic valve replacement (TAVR)
Balloon valvuloplasty (palliative)
Medications for symptom control
ACE inhibitors
Diuretics
Regular monitoring
Lifestyle modifications

Risk Factors

1Age (>65)
2Congenital bicuspid valve
3Rheumatic fever history
4Calcification
5Radiation therapy to chest
6Chronic kidney disease
7Smoking
8High cholesterol
9Male gender

Diagnostic Methods

  • 1Echocardiogram (primary)
  • 2Transesophageal echocardiogram
  • 3Cardiac catheterization
  • 4CT scan
  • 5MRI
  • 6Chest X-ray
  • 7ECG
  • 8Physical exam (systolic murmur)

Prognosis

Asymptomatic severe AS has low sudden death risk (<1%/year). Symptomatic AS has 50% 2-year mortality without intervention. Surgical AVR has 1-3% operative mortality, 70-80% 10-year survival. TAVI (transcatheter) for inoperable/high-risk patients has 70-80% 2-year survival and dramatic symptom improvement. Bioprosthetic valves last 10-15 years; mechanical require lifelong anticoagulation. Regular echocardiographic monitoring tracks progression. Heart failure and syncope indicate poor prognosis without intervention.

Prevention

  • Rheumatic fever prevention
  • Regular cardiac checkups
  • Cholesterol management
  • Blood pressure control
  • Prompt treatment of strep throat
  • Antibiotic prophylaxis (if indicated)

Research Status

Surgical aortic valve replacement (SAVR) is gold standard. Transcatheter aortic valve replacement (TAVR) for high-risk patients. No medical therapy halts progression. Research on early TAVR, valve-in-valve procedures, and transcatheter repair ongoing.

Sources

  • https://www.mayoclinic.org/diseases-conditions/aortic-valve-stenosis
  • https://www.heart.org/en/health-topics/heart-valve-problems-and-disease
  • https://www.cdc.gov/heartdisease/valve_disease.htm

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.